
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5874625
[patent_doc_number] => 20020049177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Diagnostics and therapeutics for glaucoma'
[patent_app_type] => new
[patent_app_number] => 09/796008
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23667
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049177.pdf
[firstpage_image] =>[orig_patent_app_number] => 09796008
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/796008 | Diagnostics and therapeutics for glaucoma | Feb 27, 2001 | Issued |
Array
(
[id] => 654508
[patent_doc_number] => 07109027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Aβ-Peptide screening assay'
[patent_app_type] => utility
[patent_app_number] => 09/794975
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5119
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109027.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794975 | Aβ-Peptide screening assay | Feb 26, 2001 | Issued |
Array
(
[id] => 5874608
[patent_doc_number] => 20020049176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery'
[patent_app_type] => new
[patent_app_number] => 09/795651
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 55426
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795651
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795651 | Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery | Feb 26, 2001 | Abandoned |
Array
(
[id] => 1195894
[patent_doc_number] => 06726926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-27
[patent_title] => 'Gene-entrapped liposomes preparation and process for the preparation thereof'
[patent_app_type] => B2
[patent_app_number] => 09/790727
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3880
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/726/06726926.pdf
[firstpage_image] =>[orig_patent_app_number] => 09790727
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/790727 | Gene-entrapped liposomes preparation and process for the preparation thereof | Feb 22, 2001 | Issued |
| 09/623259 | VECTORS AND VIRUSES USED IN GENE THERAPY | Feb 15, 2001 | Abandoned |
Array
(
[id] => 6033358
[patent_doc_number] => 20020019350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Targeted angiogenesis'
[patent_app_type] => new
[patent_app_number] => 09/782650
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22296
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782650 | Targeted angiogenesis | Feb 11, 2001 | Abandoned |
Array
(
[id] => 5801379
[patent_doc_number] => 20020009706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Method for loading cells with an agent'
[patent_app_type] => new
[patent_app_number] => 09/779188
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11183
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009706.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779188
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779188 | Method for loading cells with an agent | Feb 7, 2001 | Abandoned |
Array
(
[id] => 6870068
[patent_doc_number] => 20030082757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/779679
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46799
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082757.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779679 | Novel proteins and nucleic acids encoding same | Feb 7, 2001 | Abandoned |
Array
(
[id] => 5828235
[patent_doc_number] => 20020068283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Suppressor mutations for common P53 cancer mutations'
[patent_app_type] => new
[patent_app_number] => 09/776695
[patent_app_country] => US
[patent_app_date] => 2001-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15847
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068283.pdf
[firstpage_image] =>[orig_patent_app_number] => 09776695
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/776695 | Suppressor mutations for common P53 cancer mutations | Feb 5, 2001 | Abandoned |
Array
(
[id] => 6016842
[patent_doc_number] => 20020103117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Use of protein kinase-inhibitor-alpha'
[patent_app_type] => new
[patent_app_number] => 09/773776
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5311
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103117.pdf
[firstpage_image] =>[orig_patent_app_number] => 09773776
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/773776 | Use of protein kinase-inhibitor-alpha | Feb 1, 2001 | Abandoned |
Array
(
[id] => 1059615
[patent_doc_number] => 06852705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'DNA vaccines for farm animals, in particular bovines and porcines'
[patent_app_type] => utility
[patent_app_number] => 09/766442
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20072
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852705.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766442 | DNA vaccines for farm animals, in particular bovines and porcines | Jan 18, 2001 | Issued |
Array
(
[id] => 686845
[patent_doc_number] => 07078388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'DNA vaccines for farm animals, in particular bovines and porcines'
[patent_app_type] => utility
[patent_app_number] => 09/760574
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19167
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760574
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760574 | DNA vaccines for farm animals, in particular bovines and porcines | Jan 15, 2001 | Issued |
Array
(
[id] => 6245640
[patent_doc_number] => 20020046409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Roles for Nkx3.1 in prostate development and cancer'
[patent_app_type] => new
[patent_app_number] => 09/756151
[patent_app_country] => US
[patent_app_date] => 2001-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11008
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20020046409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756151
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756151 | Roles for Nkx3.1 in prostate development and cancer | Jan 5, 2001 | Abandoned |
Array
(
[id] => 6495977
[patent_doc_number] => 20020025306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Methods of increasing the glucose responsiveness of pancreatic ss-cells'
[patent_app_type] => new
[patent_app_number] => 09/755539
[patent_app_country] => US
[patent_app_date] => 2001-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7822
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025306.pdf
[firstpage_image] =>[orig_patent_app_number] => 09755539
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/755539 | Methods of increasing the glucose responsiveness of pancreatic ss-cells | Jan 4, 2001 | Abandoned |
Array
(
[id] => 6921393
[patent_doc_number] => 20010028878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'In vitro maturation of human oocytes in one day'
[patent_app_type] => new
[patent_app_number] => 09/746656
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5431
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20010028878.pdf
[firstpage_image] =>[orig_patent_app_number] => 09746656
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/746656 | In vitro maturation of human oocytes in one day | Dec 21, 2000 | Abandoned |
Array
(
[id] => 5921906
[patent_doc_number] => 20020115211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => ' A METHOD FOR IN VITRO MATURATION OF HUMAN GAMETES\n '
[patent_app_type] => original-publication-amended
[patent_app_number] => 09/746633
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6458
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09746633
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/746633 | A METHOD FOR IN VITRO MATURATION OF HUMAN GAMETESn | Dec 21, 2000 | Abandoned |
Array
(
[id] => 6908049
[patent_doc_number] => 20010010816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus'
[patent_app_type] => new
[patent_app_number] => 09/738847
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19049
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20010010816.pdf
[firstpage_image] =>[orig_patent_app_number] => 09738847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/738847 | Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus | Dec 14, 2000 | Issued |
| 09/673291 | Gene screening methods and related assays | Dec 11, 2000 | Abandoned |
Array
(
[id] => 1112786
[patent_doc_number] => 06803232
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-12
[patent_title] => 'NPY-Y7 receptor gene'
[patent_app_type] => B1
[patent_app_number] => 09/719088
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4919
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/803/06803232.pdf
[firstpage_image] =>[orig_patent_app_number] => 09719088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/719088 | NPY-Y7 receptor gene | Dec 7, 2000 | Issued |
Array
(
[id] => 6882921
[patent_doc_number] => 20010049393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Methods for defining MYC target genes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/732998
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8052
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049393.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732998
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732998 | Methods for defining MYC target genes and uses thereof | Dec 6, 2000 | Abandoned |